Our laboratory and others have demonstrated a significant association of high IGF-I circulatory levels, low IGFBP-3 levels, and a correlation with breast cancer risk and outcome [10-14], notably among African-American and Hispanic/Latina women [11]. Here, IGFBP3 is linked to breast carcinoma.